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ABSTRACT  
Background and aims 
FTO variants are among genetic variants frequently associated with obesity. We analyzed the 
association between FTO rs1421085 polymorphism and obesity, dietary intake, 
cardiorespiratory fitness, physical activity and socioeconomic status (SES) from age 9 to 25 
years.  
Methods and results 
The sample included both birth cohorts (originally n = 1176) of the Estonian Children 
Personality Behaviour and Health Study. The association between FTO rs1421085 and 
obesity, dietary intake, cardiorespiratory fitness, physical activity and SES from age 15 to 25 
years was assessed using linear mixed-effects regression models. Associations at ages 9 
(younger cohort only), 15, 18 and 25 years were assessed by one-way ANOVA. 
Male C-allele carriers had significantly (p < 0.05) higher body mass index (BMI), sum of 5 
skinfolds, body fat percentage and hip circumference from age 15 to 25 years. Findings were 
similar at age 9 years. In female subjects, waist-to-hip ratio was significantly greater in CC 
homozygotes. Interestingly, female CC homozygotes had a greater decrease in the rate of 
change in daily energy intake and lipid intake per year and higher physical activity score at 
every fixed time point. Moreover, in females, an effect of FTO × SES interaction on measures 
of obesity was observed. 
Conclusion 
The FTO rs1421085 polymorphism was associated with obesity and abdominal obesity from 
childhood to young adulthood in males, and with abdominal obesity from adolescence to 
young adulthood in females. This association is rather related to differences in adipocyte 
energy metabolism than lifestyle.
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INTRODUCTION 
Obesity is a major public health concern, which affected more than 600 million adults in year 
2015 [1]. High body mass index (BMI) is a risk factor for several chronic diseases, whereas 
cardiovascular disease and diabetes are the leading causes of deaths related to high BMI [1]. 
Obesity is a multifactorial condition with no single linear cause-and-effect, and factors like 
genetics, biology, individual behaviours, environment and larger societal forces playing a role 
[2]. 
The application of genome wide association studies (GWAS) more than 10 years ago enabled 
to find associations between several genetic variants and different traits [3].  
In humans, the gene encoding fat mass and obesity-associated protein (FTO) is located in 
chromosome 16, is over 400 kb in size, and has 9 exons [4]. The FTO gene was originally 
identified in 1999 in a fused-toe mouse model, and called Fatso because of its size [5]. In 
year 2007 a GWAS by Frayling et al. first demonstrated the association between FTO 
rs9939609 single nucleotide polymorphism (SNP) and obesity [6]. In the same year, these 
findings were confirmed by two other research groups [7,8]. Subsequently, several GWAS 
have affirmed the association between different FTO SNPs and BMI in children and adults 
[9–11]. While the studies on FTO genotype have addressed different variants and analysed 
different variables, some of the variants, e.g., rs1421085, rs17817449 and rs9939609, are in 
strong linkage disequilibrium (pairwise r2 0.85–97) [12,13] and will thus be discussed 
together. 
It is difficult to estimate the contribution of genes to BMI variability as heritability estimates 
of BMI differ ranging from 0.24 to 0.81 in family studies and 0.47 to 0.90 in twin studies [14]. 
There is also evidence of a genotype-age and genotype-environment interaction that 
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contribute to BMI variation [15]. Previous reports about the complex biological mechanism 
of FTO intronic variants have been inconclusive. It is probable that multiple factors 
associated with both energy consumption and expenditure are involved. Several studies 
have been conducted to assess the association between FTO variants and eating behaviour. 
Stutzmann et al. (2009) did not find an association between FTO rs1421085 genotype and 
snacking or eating large amounts of food in adolescence and adults with European ancestry 
[16] whereas Wardle et al (2009) found that the common FTO rs9939609 T-allele is 
protective of overeating among children aged 4–5 years [17].  FTO rs1421085 C-allele has 
been associated with higher perceived hunger score [18], but FTO rs9939609 was not 
associated with altered postprandial responses in hunger hormones and metabolic flexibility 
[19]. Inversely, FTO rs9939609 (or a proxy) risk allele has been associated with lower energy 
intake and lower fat and protein intake, when adjusted to body weight [20]. A study by 
Claussnitzer et al. (2015) demonstrated a role of FTO rs1421085 C-allele in IRX3 and IRX5 
expression in preadipocytes, whereas higher expression was associated with reduced white 
adipocyte browning, resulting in reduced mitochondrial thermogenesis [21]. There is also 
evidence that the effect of FTO may be modified by environment. Importantly, Foraita et al. 
(2015) observed an interaction between SES and FTO rs9939609 in childhood obesity [22].  
Although evidence for the association between FTO intronic variants and obesity is strong, 
the biological mechanism and the age when the differences occur are still unknown.  In 
previous studies the C-allele of the FTO rs1421085 gene has been proposed as the risk allele 
[18], so in the present this study we aimed at clarification of the association between the 
FTO rs1421085 C-allele and measures of obesity and abdominal obesity with examining also 
dietary intake, cardiorespiratory fitness, physical activity and socioeconomic status from 
childhood to young adulthood in a longitudinal birth cohort study.
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METHODS 
Study sample 
The study sample consisted of both birth cohorts of the longitudinal Estonian Children 
Personality, Behaviour and Health Study (ECPBHS) (Table 1). The sample was originally 
formed for the European Youth Heart Study (years 1998/1999) and was subsequently 
incorporated into ECPBHS. The rationale and procedure for the original sample formation 
has been described in detail elsewhere [23]. In brief, all schools of Tartu County, Estonia, 
that agreed to participate (54 of the total of 56) were included into the sampling and 25 
schools were selected in order to reach the intended n = 1000. All children from grades 3 
(younger birth cohort, aged 9 years) and grades 9 (older birth cohort, aged 15 years) were 
invited to participate [24]. Follow-up studies for the younger birth cohort took place in age 
15 years (n = 483), 18 years (n = 454) and 25 years (n = 441) and for the older birth cohort in 
age 18 years (n = 417 + additional 62) and 25 years (n = 541). Hence, even while accounting 
for the attrition the sample still comprises more than 60% of the original sampling target. 
The cohorts are merged in the analyses because previous studies have revealed no evidence 
of body composition regulation being related to birth cohort [25,26].  Sample for this 
analysis excluded pregnant individuals (2 at age 18 and 25 at age 25). Written informed 
consent was obtained from the subjects and, in case of subjects under the age 18, also from 
their parents. Data were collected and measurements made during a laboratory visit unless 
indicated otherwise. The study was approved by the Ethics Review Committee on Human 
Research of the University of Tartu (license numbers 49/30, 151/11, 197T-14, 235/M-20) and 
was conducted in accordance with the Declaration of Helsinki.  
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Anthropometric measurements  
Height and body weight were measured using standardized procedures by experienced 
researchers (mostly by the same person throughout the longitudinal study), and BMI was 
calculated. A Harpenden caliper (Baty, West Sussex, England) was used to measure skinfold 
thickness from the left side of the body at the biceps, triceps, subscapular, suprailiac and 
medial calf areas. Body fat percentage (BF%) was calculated using a formula based on values 
of skinfold thickness (biceps, triceps, subscapular, suprailiac) [27,28]. Waist circumference 
was measured between the lower rib margin and the iliac crest, at the end of gentle 
expiration. Hip circumference was measured over the buttocks, at the level of the great 
trochanter. Waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) were calculated. All 
anthropometrical measurements were taken twice and a mean value was used in the 
analysis.  
 
Dietary intake 
The subjects were asked to complete a 24h (year 1998), 48h (years 2001, 2004, 2007) or 72h 
(years 2008, 2014) diet record at home during the day(s) before the study day. On the study 
day a face-to-face interview, using pictures of portion sizes [29], was performed to specify 
portion sizes that were not recorded in the food diary. Where data on two or three days was 
available the mean consumption was calculated. To assess dietary intake the Finnish Micro-
Nutrica Nutritional Analysis program (Estonian version 2.0, Tallinn University of Technology, 
Food Processing Institute, Estonia) and the Estonian NutriData food consumption database 
(versions 4.0–7.0, National Institute for Health Development, Estonia) were used [25].  
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Cardiorespiratory fitness and physical activity score 
Cardiorespiratory fitness (CRF) has been reported as a strong predictor of numerous health 
outcomes and all-cause mortality [30]. CRF was defined as maximum power output (MPO) 
per kilogram of body weight (MPO/kg) and determined by a maximum cycle-ergometer test. 
The protocol for CRF originates from the European Youth Heart Study and has been 
validated against direct measurement of VO2max. The correlation between VO2max 
measurements and the maximum power output was 0.96 [31]. The procedure of the cycle-
ergometer test has been described in detail elsewhere [32]. In short, after a warming up 
period of 3 minutes, subjects pedaled at a self-selected rate between 60–80 rpm. The initial 
workload for male subjects was set at 50 W, increasing by 50 W every 3 minutes and the 
initial workload for female subjects was set at 40 W, increasing by 40 W every 3 minutes 
until exhaustion. Participants were encouraged by the researcher throughout the cycle-
ergometer test and monitored by medical personnel to achieve their maximal performance 
safely. The following formula was used to calculate MPO: W1 + (W2 × t/180), where W1 is 
the work rate at the last fully completed stage, W2 is the work rate increment at the final 
incomplete stage, and t is the time in seconds at the final incomplete stage.  
Physical activity levels were evaluated using self-reported and parent-reported 
questionnaires. At ages 9 and 15 years the questions included participation in training 
groups and physical activity lessons and self-evaluated physical activity patterns. Questions 
reflecting participation in training groups and parent-reported physical activity patterns 
were included at age 18 years. At age 25 years questions including the number of days 
during the previous week that participants were active for at least 30 minutes and number 
of days, that participants were involved in work related moderate to vigorous physical 
activity, were used. For each answer option a numerical value was given, and individual 
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physical activity scores were computed. The number of questions and thus the possible 
maximal physical activity score varied in different age points. To account for that physical 
activity scores were standardized and z-scores were used in longitudinal analysis.    
 
Socioeconomic status score 
Self-reported and parent-reported questionnaires were used to assess socioeconomic status 
(SES). To calculate a SES score, questions about parental education level (ranging from 
primary and basic education to higher education), total household income (divided into 
income groups) and self-reported or parent reported SES compared to peers (ranging from 
poor to among the wealthiest in the country) were used at ages 15 and 18 years. At age 25 
years, questions about level of education of the subject, total household income and self-
reported SES assessment compared to peers, was used. Individual SES scores were 
calculated by matching a numerical value for each answer option. SES scores were 
standardized and z-scores were used in longitudinal analysis.  
 
Genotyping of FTO rs1421085 
Genomic DNA was extracted from venous blood samples using Qiagen QIAamp® DNA Blood 
Midi Kit. The real-time polymerase chain reaction (RT-PCR) for genotyping the 
FTO rs1421085 polymorphism was performed using a TaqMan Pre-Designed SNP Genotyping 
Assay (Applied Biosystems; Foster City, CA, USA) C___8917103_10 containing primers and 
fluorescent probes. Genotyping reactions were performed in a total volume of 10 µl with 
~25 ng of template DNA. RT-PCR reaction components and final concentrations were as 
follows: 1:5 5 x HOT FIREPol® Probe qPCR Mix Plus (ROX) (Solis BioDyne) and 1:20 80 x 
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TaqMan Primers Probe. Context sequence [VIC/FAM] was as follows: 
TAGCAGTTCAGGTCCTAAGGCATGA[C/T]ATTGATTAAGTGTCTGATGAGAATT. 
Reactions were performed on the Applied Biosystems ViiA™ 7 Real-Time PCR System. The 
amplification procedure consisted of an initial denaturation step at 95 °C for 12 min and 40 
cycles of 95 °C for 15 s and 60 °C for 1 min. Positive and negative controls were added to 
each reaction plate. No inconsistencies occurred. Genotyping was performed blind to all 
phenotypic data.  
 
Statistical analysis 
Statistical analysis was performed using Stata software, version 14 (StataCorp LP, College 
Station, Texas, USA). Significance level was set at 0.05. Linear mixed-effects regression 
models with random intercept and random slope which  account for the correlations 
between repeated measurements within each individual and use all available observations 
[33], were fitted to estimate the longitudinal association between FTO rs1421085 genotype 
and obesity, abdominal obesity, dietary intake and SES score from 15 to 25 years of age. 
Models with random intercept and slope allow individual variation not only in baseline 
values, but also in terms of mean response over time, giving the model more flexibility to fit 
the data [34]. 
Models for measures of obesity and abdominal obesity were later adjusted to daily energy 
intake, standardized physical activity score and standardized socioeconomic status (sSES) × 
FTO interaction. Due to non-linearity a mixed-effects regression model with quadratic trends 
was fitted to estimate the association between FTO, CRF and physical activity score. Models 
with sex × FTO and sex × time interactions were fitted to test if the effect of FTO genotype is 
different in male and female subjects. 
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Measurements of obesity, abdominal obesity, dietary intake, physical activity and SES at 
baseline (age 15 years) and at follow up points (18 years and 25 years) were defined as the 
dependent variables. FTO rs1421085 genotype (TT, TC, CC) was defined as the independent 
variable. TT-homozygotes were used as the reference group. Time was treated as a 
continuous variable.  
The likelihood-ratio (LR) test was used to assess the goodness of fit of the statistical models. 
Where interaction with time was not significant and the LR test did not show superiority of 
the more complicated model, interaction with time was not included in the final model. 
Unstructured covariance structure and restricted maximum likelihood method was used. 
Heteroscedasticity was not detected based on graphical examination of standardized 
residual versus fitted values plot. 
Continuous variables are presented as means and standard deviations and grouped by FTO 
rs1421085 genotype, age and sex. Differences in anthropometric measurements, dietary 
intake and physical activity between FTO rs1421085 genotype at ages 9, 15, 18 and 25 years 
were assessed by one-way ANOVA. The p values obtained from the pairwise comparisons 
were corrected by the Bonferroni method. 
 
RESULTS 
FTO rs1421085 genotype distribution 
All necessary data for analyses was available at different ages as follows: 15 years n = 1074 
(male 44.7%), 18 years n = 914 (male 43.8%) and 25 years n = 925 (male 45.2%). The 
distribution of TT, CT and CC genotypes of the FTO rs1421085 was 31.2%, 48.3%, 20.5% 
respectively, the C-allele frequency was 0.45. Allele frequencies agree with National Center 
for Biotechnology Information database (C-allele frequency 0.45 for Estonia) and published 
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reports on European ancestry. This is on the higher end of worldwide prevalence. The lowest 
C-allele frequency in the NCBI database is for Vietnamese (0.15). There was no significant 
difference in the distribution of genotype frequencies at age 15 years between male (TT = 
153, 31.9%; TC = 230, 47.9%; CC = 97, 20.2%) and female (TT = 182, 30.6%; TC = 289, 48.7%; 
CC = 123, 20.7%) subjects (χ2 test, p = 0.909). Genotype frequencies were in Hardy–
Weinberg equilibrium. 
 
Measurements of obesity 
According to the linear mixed-effects regression model male TC heterozygotes had 
significantly (p < 0.05) higher body weight and TC heterozygotes and CC homozygotes had 
higher BMI, sum of 5 skinfolds and BF%, compared to TT homozygotes at each time point 
(Figure 1). Similar effect was observed in the adjusted models. The rate of change among 
male subjects in body weight was 1.92 kg (95% CI 1.83 to 2.01), in BMI 0.46 kg/m2 (95% CI 
0.43 to 0.48), in sum of 5 skinfolds 2.38 mm (95% CI 2.10 to 2.67) and in BF% 0.21 % (95% CI 
0.15 to 0.26) per year (Table 2). In female subjects the rate of change in body weight and 
sum of 5 skinfolds per one unit rise in the SES score differed significantly (p < 0.05) between 
TT homozygotes and CC homozygotes in the adjusted model (Tables 2–3).  
Interaction terms for sex × FTO were significant (p < 0.05) for sum of 5 skinfolds and BF% and 
a trend (0.05 ≤ p < 0.10) for BMI was observed. The interaction terms for sex × time were 
significant (p < 0.05) for body weight, BMI, sum of 5 skinfolds and BF%.  
One-way ANOVA test at ages 9, 15, 18 and 25 years revealed that male CC homozygotes had 
significantly higher BMI (by 0.84 kg/m2, 95% CI 0.02 to 1.65, p = 0.042), compared to TT 
homozygotes and greater sum of 5 skinfolds compared to TC heterozygotes (by 4.50 mm, 
95% CI 0.27 to 8.72, p = 0.033) and TT homozygotes (5.88 mm, 95% CI 0.45 to 11.31, p = 
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0.029) at age 9 years. Male TC heterozygotes had significantly higher sum of 5 skinfolds (by 
6.43 mm, 95% CI 1.63 to 11.23, p = 0.004) and BF% (by 1.65 %, 95% CI 0.46 to 2.84, p = 
0.003) at age 15 years compared to TT homozygotes. At age 18 years both CC homozygotes 
and TC heterozygotes had significantly higher sum of 5 skinfolds (by 11.47 mm, 95% CI 1.24 
to 21.70, p = 0.022; 10.87 mm, 95% CI 2.84 to 18.90, p = 0.004) and BF % (by 2.21 %, 95% CI 
0.13 to 4.29, p = 0.033; 2.10 %, 95% CI 0.46 to 3.75, p = 0.007) compared to TT homozygotes, 
respectively. No statistically significant associations were observed by one-way ANOVA 
between FTO rs1421085 genotype and measures of obesity in female subjects 
(Supplementary Tables 1–4).  
 
Measurements of abdominal obesity 
Hip circumference measure was significantly (p < 0.05) higher in male CC homozygotes and 
TC heterozygotes, compared to TT homozygotes at each time point. In the adjusted models, 
similar effect was observed. The rate of change among male subjects in hip circumference 
was 1.13 cm (95% CI 1.07 to 1.19) per year (Table 2). In female subjects, at each time point, 
WHR was significantly (p < 0.05) greater in CC homozygotes compared to TT homozygotes. 
The rate of change among female subjects in WHR was 0.003 units (95% CI 0.002 to 0.003) 
per year (Table 2). In the adjusted model a significant difference (p < 0.05) in the rate of 
change per one unit rise in the SES score between TT homozygotes and CC homozygotes in 
waist circumference, hip circumference and WHtR in female subjects was observed (Tables 
2–3).  
Interaction terms for sex × FTO were significant (p < 0.05) for hip circumference and WHR. 
The interaction terms for sex × time were significant (p < 0.05) for waist circumference, hip 
circumference, WHR, and WHtR.  
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One-way ANOVA test at ages 9, 15, 18 and 25 years demonstrated that male CC 
homozygotes had significantly higher hip circumference (by 2.54 cm, 95% CI 0.26 to 4.81, p = 
0.023) at age 9 years and TC heterozygotes had significantly larger hip circumference (by 
2.00 cm, 95% CI 0.11 to 3.89, p = 0.034) at age 18 years, compared to TT homozygotes. One-
way ANOVA test did not identify any significant associations between measures of 
abdominal obesity and FTO rs1421085 genotype in female subjects (Supplementary Tables 
1–4). 
 
Dietary intake 
Models for male subjects demonstrated that TC heterozygotes had significantly (p < 0.05) 
lower protein and lipid intake in grams per kilogram of body weight (g/kg) and a lower lipid 
intake as a percentage from daily energy intake (E%), compared to TT homozygotes. The rate 
of change among male subjects was in protein intake -0.02 g/kg (95% CI -0.02 to -0.01), in 
lipid intake -0.05 g/kg (95% CI -0.06 to -0.04) and in lipid intake 0.01 E% (95% CI -0.9 to 0.10) 
per year (Table 4). In female subjects, linear mixed-effects regression models showed a 
significant difference in the rate of change per year in daily energy intake (kcal) (p = 0.04 for 
interaction) and lipid intake (g/kg) (p = 0.035 for interaction) between female CC 
homozygotes and TT homozygotes (Table 4), the former having a larger decrease in the rate 
of change per year in both daily energy intake (kcal) and lipid intake (g/kg) (Figure 1, Table 
5).  
One-way ANOVA test at ages 9, 15, 18 and 25 years demonstrated that at age 25 years 
female CC homozygotes had significantly higher protein intake (E%) (by 1.28 %, 95% CI 0.16 
to 2.40, p = 0.019) compared to TT homozygotes. One-way ANOVA did not identify 
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statistically significant associations between FTO rs1421085 genotype in male subjects 
(Supplementary Tables 5–8). 
 
Cardiorespiratory fitness and physical activity score 
According to the mixed-effects regression models with quadratic trends a trend (p ≥ 0.05 < 
0.1) in MPO/kg between TC heterozygotes and TT homozygotes was observed, but with 
opposite direction in male and female subjects. Physical activity score was 0.162 units (95% 
CI 0.003 to 0.321, p = 0.046) greater in female CC homozygotes compared to TT 
homozygotes in every fixed timepoint (Figure 1, Table 6).  
One-way ANOVA test at ages 9, 15, 18 and 25 years did not demonstrate a statistically 
significant difference in CRF or physical activity score between FTO rs1421085 genotypes in 
male or female subjects (Supplementary Tables 9–12). 
 
Socioeconomic status score 
Models for male subjects demonstrated that TC heterozygotes and CC homozygotes had 
higher standardized SES score at each time point. The rate of change among male subjects in 
standardized SES was –0.01 units (95% CI –0.02 to 0.01) per year (Table 7). No difference 
was found among female subjects (Table 7).  
One-way ANOVA test at ages 9, 15, 18 and 25 years demonstrated that at age 25 years male 
CC homozygotes had significantly higher SES score (by 0.86 units, 95% CI 0.06 to 1.67, p = 
0.030) and standardized SES score (by 0.34 units, 95% CI 0.02 to 0.65, p = 0.030) compared 
to TT homozygotes. No statistically significant associations between FTO rs1421085 
genotypes were identified in female subjects by one-way ANOVA (Supplementary Tables 13–
15).
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DISCUSSION 
We observed that male FTO rs1421085 C-allele carriers had significantly higher body weight, 
BMI, sum of 5 skinfolds, BF%, and hip circumference from 15 to 25 years of age with no 
interaction with time; in fact, these associations were present already at age 9 as cross-
sectionally analyzed in the single birth cohort studied at that age. In female subjects WHR 
was significantly higher in CC homozygotes compared to TT homozygotes throughout the 
study period. A meta-analysis by Hertel et al. (2011) found similar results, when assessing 
the relationship between FTO rs9939609, type 2 diabetes, and BMI across the life span in 
41,504 Scandinavians. FTO rs9939609 genotype had a strong effect on BMI (0.28 kg/m2 per 
risk allele [P = 2.0 × 10−26] with no rs9939609 × age interactions on obesity-related traits. 
They concluded that the effect of FTO rs9939609 is already present in youth, setting a 
threshold for BMI, and staying relatively stable across adulthood [35]. The Baltimore 
Longitudinal Study of Aging observed a dose-dependent relationship between FTO 
rs1421085 and body mass index during ageing, where BMI was highest in CC homozygotes 
and lowest in TT homozygotes [36]. Interestingly, the trajectories of BMI over time 
significantly differed between FTO rs1421085 genotype (χ2 = 13.7, df = 4,P= 0.008) [36]. 
Several GWAS have observed an association between FTO intronic variants and BMI 
variation in children [10,37,38] and adults [9,11], but the onset of the effect is still unknown. 
Barton et al. (2016) demonstrated that higher placental FTO expression was associated with 
faster fetal growth between 11 and 34 weeks gestation where FTO rs9939609 AA 
homozygous fetuses had faster biparietal diameter and head circumference velocities, but 
not abdominal circumference growth velocity [39]. However no significant association 
between FTO SNPs and birth weight has been noted [40,41].  
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FTO is expressed in various tissues throughout the body [6,7,42,43] whereas its levels are 
particularly high in the hypothalamus [42,43]. Therefore, several studies have assessed the 
association between FTO intronic variants and dietary intake. In mice, FTO overexpression 
has been associated with obesity and increased in food intake [44]. FTO rs1421085 risk allele 
has also been associated with greater perceived hunger scores (p = 0.007) [18]. Harbron et 
al. (2014) showed that FTO rs17817449 GG homozygote individuals had higher intake of 
high-fat foods (1.74, SE 0.87, p = 0.049) and refined starches (0.67, SE 0.30, p = 0.029), but 
no significant association was found with consumption of energy dense drinks or snacks [18].  
We observed that female FTO rs1421085 CC homozygotes had a greater decrease in the rate 
of change in daily energy intake (kcal) and lipid intake (g/kg) per year from age 15 to 25 
years, compared to TT homozygotes. We also found a lower protein (g/kg) and lipid (g/kg) 
intake and a lower lipid intake (E%), in male heterozygotes, compared to TT homozygotes. 
Similar results were observed by Livingston et al. (2015) in a systematic review and a meta-
analysis, which demonstrated that FTO risk allele carriers had significantly lower energy 
intake (p = 0.028) and total fat (p = 0.004), carbohydrate (p = 0.005) and protein (p = 0.001) 
intake, when adjusted for body weight [20].  
Although intronic variants in the FTO gene have not been associated with physical activity 
[45,46], the effect of FTO risk allele on obesity has shown to be decreased by physical 
activity [46,47]. Kilpeläinen et al. (2011) conducted a random effects meta-analysis of cross-
sectional data of 218 166 adults and 19 268 children to assess if physical activity affects the 
effect of FTO on obesity. The FTO rs9939609 SNP or a proxy with linkage disequilibrium r2 > 
0.8 in each study was used. They found that physical activity reduces the effect of FTO on 
BMI (p for interaction = 0.005), waist circumference (p for interaction = 0.002) and body fat 
percentage (p for interaction = 0.02) in adults [46]. In our study, we demonstrated that in 
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female subjects, physical activity scores were significantly greater in CC homozygotes 
compared to TT homozygotes in every fixed timepoint, but no statistically significant 
associations were identified in CRF between FTO rs1421085 genotype. 
The observed reduction in daily energy intake and significantly greater standardized physical 
activity score among female CC homozygotes from age 15 to 25 years led us to hypothesize 
that the lack of association in female subjects between FTO rs1421085 genotype and 
measures of obesity might be due to lifestyle. Thus, models for measures of obesity and 
abdominal obesity were adjusted for daily energy intake and standardized physical activity 
score. Nevertheless, in females, differences in measure of obesity between FTO genotype 
were not observed in the adjusted models. Finally models with sex × FTO and sex × time 
interactions were fitted, which revealed sex and FTO rs1421085 genotype interactions.  
Interestingly, we observed an interaction between FTO rs1421085 genotype and 
standardized socioeconomic status (SES) score in female subjects, where increasing SES 
status score led to an increase in measurements of obesity in TT homozygotes, but to a 
decrease in CC homozygotes. An interaction between FTO rs9939609 and SES was previously 
demonstrated by Foraita et al. (2015) in children, where TT homozygotes where more 
protected by a favourable socioeconomic environment [22]. The mechanism behind such 
interactions is not clear and should be explored if further studies confirmed the significance 
of either type of FTO genotype and SES interactions as reported previously [22] and 
herewith. 
Abundant research has been conducted to assess the obesity increasing effect of FTO 
variants through nutrition and physical activity; however, no consistent relationship 
between FTO rs1421085 and candidate mechanisms such as eating behaviour traits [16] and 
altered resting energy expenditure [48] has been found. Research by Claussnitzer et al. 
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(2015) instead demonstrated that the obesity increasing effect of FTO rs1421085 SNP T to C 
causes a disruption in the ARID5B-mediated repression of IRX3 and IRX5 expression in 
preadipocytes which leads to excessive accumulation of triglycerides, increased adipocyte 
size, reduced mitochondrial oxidative capacity and reduced white adipocyte browning, 
resulting in reduced mitochondrial thermogenesis [21]. However, the authors did not assess 
whether carriers of the FTO rs1421085 C-allele have lower energy expenditure.  
The ECPBHS is a longitudinal birth cohort study with population representative sample and 
comprehensive data, but it has some limitations. The sample of ECPBHS consists of 
individuals of only European descent and therefore we cannot be sure if the associations are 
similar in other ethnicities. Additionally, the effect of FTO rs1421085 genotype on markers of 
obesity and abdominal obesity in males could already be observed at age 9, the earliest age 
of observation, and thus we are unable to describe the age when the differences emerge. 
Our findings confirm that the effect of FTO rs1421085 genotype on markers of obesity is 
already manifested in childhood in males. In females, on abdominal obesity, from 
adolescence, remaining rather stable from adolescence to young adulthood with no 
genotype × time interaction. A sex × FTO rs1421085 and sex × time interaction was also 
observed. Moreover, in female subjects SES × FTO rs1421085 interaction was detected. Our 
findings indicate that the effect of FTO rs1421085 risk allele on obesity is not mediated by 
daily energy intake, macronutrient intake or physical activity, but can differ in age groups 
and sex and be modified by SES. When analyzing biological mechanisms behind FTO obesity 
increasing effect, further research should consider the potential effect modifying impact of 
sex, age and socioeconomic environment. 
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Table 1. Anthropometric measurements, dietary intake, cardiorespiratory fitness, physical activity score and socioeconomic status score (mean and SD) at 
age 15 years, 18 years and 25 years of the ECPBHS sample by FTO rs1421085 genotype and age (n).  
 15 years old 18 years old 25 years old 
 TT TC CC TT TC CC TT TC CC 
Age (years) 15.2 ± 0.7 (335) 15.2 ± 0.7 (519) 15.2 ± 0.7 (220) 17.8 ± 0.7 (273) 17.9 ± 0.8 (455) 17.9 ± 0.9 (184) 24.7 ± 0.6 (282) 24.8 ± 0.6 (448) 24.8 ± 0.8 (194) 
Height (cm)  169.5 ± 8.2 (335) 169.3 ± 8.3 (519) 169.5 ± 7.5 (220) 1737.7 ± 9.3 (268) 173.1 ± 9.0 (444) 173.0 ± 8.5 (177) 174.4 ± 9.4 (282) 173.9 ± 9.2 (447) 174.0 ± 8.7 (194) 
Weight (kg)  58.5 ± 9.7 (335) 59.1 ± 10.2 (519) 59.6 ± 11.7 (220) 66.1 ± 11.5 (268) 66.4 ± 12.2 (444) 67.8 ± 13.8 (177) 71.7 ± 15.2 (282) 72.5 ± 15.6 (447) 74.1 ± 17.3 (194) 
BMI (kg/m²)  20.3 ± 2.6 (335) 20.6 ± 2.8 (519) 20.7 ± 3.5 (220) 21.8 ± 2.8 (268) 22.1 ± 3.3 (444) 22.6 ± 4.0 (177) 23.4 ± 3.8 (282) 23.8 ± 4.1 (447) 24.4 ± 5.0 (194) 
Waist (cm)  68.3 ± 5.8 (335) 68.8 ± 6.4 (519) 69.1 ± 7.5 (220) 73.2 ± 7.4 (268) 73.6 ± 8.5 (444) 74.0 ± 9.6 (177) 78.8 ± 11.0 (282) 79.7 ± 11.5 (447) 80.6 ± 12.2 (194) 
Hip (cm)  90.1 ± 6.4 (333) 90.9 ± 6.6 (519) 90.8 ± 7.5 (220) 94.0 ± 6.7 (268) 94.6 ± 6.8 (444) 95.1 ± 8.3 (177) 98.8 ± 8.1 (282) 99.3 ± 8.7 (447) 100.0 ± 9.5 (194) 
WHR (units) 0.76 ± 0.05 (333) 0.76 ± 0.05 (519) 0.76 ± 0.05 (220) 0.78 ± 0.06 (268) 0.78 ± 0.06 (444) 0.78 ± 0.06 (177) 0.80 ± 0.07 (282) 0.80 ± 0.07 (447) 0.80 ± 0.07 (194) 
WHtR (units) 0.40 ± 0.03 (335) 0.41 ± 0.03 (519) 0.41 ± 0.04 (220) 0.42 ± 0.04 (268) 0.43 ± 0.04 (444) 0.43 ± 0.05 (177) 0.45 ± 0.06 (282) 0.46 ± 0.06 (447) 0.46 ± 0.06 (194) 
Sum of 5 skinfolds 
(mm) 
52.3 ± 24.1 (335) 55.5 ± 25.9 (519) 55.4 ± 28.3 (220) 65.6 ± 31.9 (268) 69.5 ± 33.5 (444) 73.5 ± 36.3 (175) 74.2 ± 35.8 (282) 76.6 ± 36.5 (446) 79.4 ± 40.0 (193) 
Daily energy 
intake (kcal) 
2236.0 ± 915.1 
(331) 
2196.5 ± 863.4 
(518) 
2249.0 ± 1017.4 
(220) 
2206.0 ± 905.7 
(268) 
2156.2 ± 906.0 
(435) 
2216.6 ± 814.3 
(176) 
2044.0 ± 786.6 
(276) 
1976.5 ± 696.8 
(442) 
1960.5 ± 688.9 
(195) 
Protein (g/kg) 1.2 ± 0.6 (331) 1.2 ± 0.5 (518) 1.2 ± 0.5 (220) 1.1 ± 0.5 (267) 1.1 ± 0.5 (435) 1.1 ± 0.4 (175) 1.1 ± 0.5 (273) 1.1 ± 0.4 (436) 1.1 ± 0.4 (192) 
Lipids (g/kg) 1.5 ± 0.8 (331) 1.5 ± 0.7 (518) 1.5 ± 0.9 (220) 1.4 ± 0.6 (267) 1.3 ± 0.6 (435) 1.4 ± 0.6 (175) 1.2 ± 0.5 (273) 1.1 ± 0.5 (436) 1.1 ± 0.4 (192) 
Carbohydrates 
(g/kg) 
4.9 ± 2.2 (331) 4.8 ± 2.2 (518) 4.8 ± 2.1 (220) 4.0 ± 1.7 (267) 4.0 ± 1.7 (435) 3.9 ± 1.5 (175) 3.4 ± 1.4 (273) 3.2 ± 1.2 (436) 3.2 ± 1.2 (192) 
Protein E% 12.9 ± 3.2 (331) 13.1 ± 3.1 (518) 13.1 ± 3.2 (220) 13.7 ± 3.1 (268) 13.7 ± 3.0 (435) 13.8 ± 2.8 (176) 15.9 ± 4.0 (276) 16.1 ± 4.0 (442) 16.3 ± 4.1 (195) 
Lipids E% 35.2 ± 8.4 (331) 35.0 ± 8.0 (518) 35.3 ± 8.0 (220) 36.6 ± 7.6 (268) 35.5 ± 7.9 (435) 37.0 ± 7.0 (176) 35.9 ± 6.9 (276) 35.7 ± 6.2 (442) 35.4 ± 5.4 (195) 
Carbohydrates 
E% 
51.9 ± 9.4 (331) 51.9 ± 8.8 (518) 51.6 ± 8.9 (220) 48.8 ± 8.4 (268) 49.4 ± 8.9 (435) 48.5 ± 7.6 (176) 46.0 ± 8.6 (276) 46.1 ± 7.9 (442) 46.2 ± 8.0 (195) 
MPO/kg 2.9 ± 0.8 (335) 2.9 ± 0.7 (514) 2.9 ± 0.7 (220) 2.5 ± 0.7 (254) 2.5 ± 0.7 (408) 2.4 ± 0.7 (167) 2.7 ± 0.7 (269) 2.7 ± 0.7 (424) 2.6 ± 0.8 (190) 
Activity score 2.6 ± 1.1 (323) 2.7 ± 1.0 (498) 2.7 ± 1.1 (211) 1.2 ± 0.8 (246) 1.2 ± 0.8 (409) 1.2 ± 0.8 (159) 4.5 ± 3.1 (290) 4.4 ± 3.1 (460) 5.0 ± 3.2 (194) 
Standardized 
activity score  
–0.07 ± 1.00 (323) 0.02 ± 1.00 (498) 0.06 ± 1.03 (211) –0.01 ± 1.00 (246) –0.01 ± 1.0 (409) 0.03 ± 1.05 (159) –0.02 ± 1.0 (290) –0.03 ± 1.00 (460) 0.15 ± 1.02 (194) 
SES score 14.7 ± 3.3 (242) 14.7 ± 3.4 (411) 14.6 ± 3.4 (165) 15.2 ± 4.0 (237) 15.6 ± 3.8 (396) 15.6 ± 3.7 (153) 14.1 ± 2.6 (285) 14.2 ± 2.5 (460) 14.6 ± 2.6 (187) 
sSES score –0.0001 ± 1.0 
(242) 
0.01 ± 1.0 (411) –0.02 ± 1.0 (165) –0.6 ± 1.0 (237) 0.03 ± 1.0 (396) 0.03 ± 1.0 (153) –0.06 ± 1.0 (285) –0.02 ± 1.0 (460) 0.14 ± 1.0 (187) 
WHR – waist to hip ratio; WHtR – waist to height ratio; MPO – maximum power output; SES – socioeconomic status; sSES – standardized socioeconomic status
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Table 2. Estimated main effects (mean and 95% CI) in male and female subjects of the ECPBHS sample in anthropometric measurements from 15 to 25 years 
of age between FTO rs1421085 genotype according to the linear mixed effects regression model. 
 MALE3 FEMALE3 MALE3 FEMALE3 
 Coeff.1 95% CI p value Coeff.1 95% CI p value Adjusted
Coeff.2 
95% CI p value Adjusted 
Coeff.2 
95% CI p 
value 
Body weight (kg)             
TC genotype  2.199 0.160; 4.238 0.035 0.039 –1.699; 1.777 0.965 1.721 –0.459; 3.901 0.122 –0.309 –2.200; 1.582 0.749 
CC genotype  2.137 –0.413; 4.687 0.100 1.623 –0.524; 3.771 0.139 1.687 –1.042; 4.415 0.226 1.560 –0.781; 3.901 0.191 
CT genotype × sSES score       0.573 –0.844; 1.990 0.428 0.064 –1.006; 1.135 0.906 
CC genotype × sSES score       –0.266 –2.093; 1.561 0.775 –1.400 –2.753; –0.046 0.043 
BMI (kg/m2)             
TC genotype  0.740 0.200; 1.280 0.007 0.083 –0.467; 0.633 0.767 0.619 0.040; 1.197 0.036 –0.011 –0.618; 0.596 0.973 
CC genotype  0.836 0.160; 1.512 0.015 0.449 –0.231; 1.129 0.196 0.671 –0.053; 1.396 0.069 0.434 –0.318; 1.186 0.258 
CT genotype × sSES score       0.054 –0.314; 0.422 0.773 –0.078 –0.436; 0.280 0.670 
CC genotype × sSES score       –0.121 –0.593; 0.352 0.616 –0.392 –0.843; 0.060 0.089 
Sum of 5 skinfolds (mm)             
TC genotype  8.046 3.957; 12.135 < 0.001 0.126 –4.461; 4.713 0.957 7.233 2.743; 11.722 0.002 –1.051 –6.037; 3.934 0.679 
CC genotype  6.837 1.717; 11.956 0.009 2.965 –2.699; 8.630 0.305 5.911 0.284; 11.538 0.039 2.471 –3.705; 8.647 0.433 
CT genotype × sSES score       1.031 –2.534; 4.596 0.571 –1.452 –5.050; 2.146 0.429 
CC genotype × sSES score       1.304 –3.271; 5.879 0.576 –5.284 –9.776; –0.792 0.021 
BF (%)             
TC genotype  1.682 0.751; 2.613 < 0.001 –0.004 –0.790; 0.782 0.992 1.492 0.472; 2.512 0.004 –0.241 –1.096; 0.613 0.580 
CC genotype  1.590 0.426; 2.755 0.007 0.272 –0.699; 1.243 0.583 1.484 0.207; 2.761 0.023 0.098 –0.961; 1.157 0.857 
CT genotype × sSES score       0.192 –0.604; 0.988 0.636 –0.179 –0.795; 0.437 0.568 
CC genotype × sSES score       0.054 –0.963; 1.071 0.918 –0.712 –1.479; 0.055 0.069 
WC (cm)             
TC genotype  0.986 –0.189; 2.161 0.100 0.482 –0.689; 1.653 0.420 0.782 –0.502; 2.066 0.232 0.298 –1.008; 1.605 0.654 
CC genotype  1.173 –0.297; 2.642 0.118 1.157 –0.289; 2.603 0.117 0.715 –0.893; 2.323 0.383 1.248 –0.372; 2.868 0.131 
CT genotype × sSES score       0.228 –0.720; 1.175 0.638 –0.223 –1.106; 0.661 0.621 
CC genotype × sSES score       0.298 –0.915; 1.510 0.630 –1.473 –2.577; –0.370 0.009 
HC (cm)             
TC genotype  1.860 0.649; 3.071 0.003 0.074 –1.108; 1.256 0.902 1.482 0.207; 2.756 0.023 0.052 –1.237; 1.341 0.937 
CC genotype  1.524 0.009; 3.039 0.049 0.362 –1.098; 1.821 0.627 1.270 –0.326; 2.866 0.119 0.388 –1.206; 1.982 0.633 
CT genotype × sSES score       0.329 –0.578; 1.236 0.477 0.153 –0.698; 1.004 0.724 
CC genotype × sSES score       –0.207 –1.368; 0.953 0.726 –1.073 –2.138; –0.007 0.048 
WHR (units)             
TC genotype  –0.0060 –0.0123; 0.0002 0.056 0.0046 –0.0021; 0.0113 0.181 –0.0051 –0.0118; 0.0016 0.133 0.0034 –0.0038; 0.0107 0.350 
CC genotype  –0.0013 –0.0091; 0.0065 0.751 0.0088 0.0005; 0.0171 0.037 –0.0049 –0.0133; 0.0035 0.255 0.0095 0.0005; 0.0184 0.038 
CT genotype × sSES score       0.0025 –0.0032; 0.0082 0.394 –0.0046 –0.0102; 0.0010 0.110 
CC genotype × sSES score 
 
 
 
 
      0.0050 –0.0022; 0.0123 0.173 –0.0069 –0.0138; 0.0001 0.052 
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WHtR (units)             
TC genotype  0.0057 –0.0008; 0.0123 0.084 0.0032 –0.0036; 0.0100 0.360 0.0049 –0.0021; 0.0119 0.173 0.0026 –0.0051; 0.0103 0.515 
CC genotype  0.0081 –0.0001; 0.0162 0.052 0.0056 –0.0029; 0.0140 0.196 0.0047 –0.0041; 0.0136 0.294 0.0061 –0.0034; 0.0157 0.210 
CT genotype × sSES score       0.0001 –0.0050; 0.0052 0.967 –0.0021 –0.0073; 0.0030 0.419 
CC genotype × sSES score       0.0014 –0.0051; 0.0079 0.677 –0.0072 –0.0137; –0.0008 0.028 
1Coefficient (Coeff.) can be interpreted as the mean difference in anthropometrical measurements between FTO rs1421085 TC and TT genotype or between CC and TT genotype at each timepoint 
2Coefficient (Coeff.) can be interpreted as the mean difference, adjusted to daily energy intake, standardized physical activity score and FTO × sSES interaction, in anthropometrical measurements between FTO 
rs1421085 TC and TT genotype or between CC and TT genotype at each timepoint 
3Average sample size by sex and FTO rs1421085 genotype at age 15, 18, and 25 years: male subjects TT = 153/119/128, CT = 231/200/204, CC= 97/81/86; female subjects TT = 182/154/155, CT = 288/256/244, CC = 
123/103/109, respectively.  
 
 
Table 3. The rate of change per standardized socioeconomic status (sSES) score unit in anthropometric measurements (mean and 95% CI) in the female 
subjects of the ECPBHS sample according to the linear mixed effects regression model with FTO rs1421085 genotype × sSES interaction. 
 TT genotype TC genotype CC genotype 
Body weight (kg) 0.176 (–0.646; 0.998)* 0.240 (–0.445; 0.925) –1.224 (–2.299; –0.149)* 
BMI (kg/m2) 0.052 (–0.223; 0.328)# –0.025 (–0.255; 0.204) –0.339 (–0.697; 0.018)# 
Sum of 5 skinfolds (mm) 2.510 (–0.270; 5.290)* 1.058 (–1.227; 3.344) –2.774 (–6.303; 0.754)* 
BF (%) 0.429 (–0.047; 0.905)# 0.250 (–0.141; 0.641) –0.283 (–0.884; 0.318)# 
WC (cm) 0.505 (–0.177; 1.187)* 0.282 (–0.280; 0.844) –0.968 (–1.836; –0.101)* 
HC (cm) 0.266 (–0.392; 0.923)* 0.419 (–0.122; 0.959) –0.807 (–1.645; 0.031)* 
WHR (units) 0.0018 (–0.0026; 0.0061)# –0.0028 (–0.0063; 0.0008) –0.0051 (–0.0105; 0.0003)# 
WHtR (units) 0.0028 (–0.0012; 0.0067)* 0.0006 (–0.0027; 0.0039) –0.0045 (–0.0095; 0.0006)* 
* p < 0.05 significant difference in the rate of change between FTO rs1421085 genotype TT and CC  
# 0.05 ≤ p < 0.10 trend in the rate of change between FTO rs1421085 genotype TT and CC  
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Table 4. Estimated main effects (mean and 95% CI) in male subjects and estimated main and 
interaction effects (mean and 95% CI) in female subjects of the ECPBHS sample in daily energy intake 
(kcal), nutrient intake (g/kg) and nutrient intake as a percentage from daily energy intake (E%) from 
15 to 25 years of age between FTO rs1421085 genotype according to the linear mixed effects 
regression model. 
 MALE3 FEMALE3 
 Coefficient1 95% CI p value Coefficient2 95% CI p value 
Energy intake (kcal)       
TC genotype  –103.172 –231.644; 25.301 0.115 234.711 –74.469; 543.892 0.137 
CC genotype  –43.858 –203.413; 115.697 0.590 402.881 23.857; 781.904 0.037 
TC genotype × time    –12.441 –28.445; 3.563 0.128 
CC genotype × time    –20.426 –39.967; –0.885 0.040 
Protein (g/kg)       
TC genotype  –0.089 –0.166; –0.013 0.022 0.194 –0.019; 0.407 0.075 
CC genotype  –0.081 –0.176; 0.015 0.097 0.164 –0.098; 0.425 0.221 
TC genotype × time    –0.010 –0.020; 0.001 0.063 
CC genotype × time    –0.008 –0.020; 0.005 0.219 
Lipids (g/kg)       
TC genotype  –0.137 –0.224; –0.051 0.002 0.136 –0.156; 0.427 0.361 
CC genotype  –0.055 –0.163; 0.052 0.313 0.367 0.010; 0.724 0.044 
TC genotype × time    –0.007 –0.022; 0.008 0.338 
CC genotype × time    –0.020 –0.038; –0.001 0.035 
Carbohydrates (g/kg)       
TC genotype  –0.214 –0.475; 0.047 0.108 0.576 -–0.213; 1.364 0.153 
CC genotype  –0.219 –0.544; 0.106 0.187 0.798 –0.171; 1.767 0.106 
TC genotype × time    –0.030 –0.067; 0.006 0.102 
CC genotype × time    –0.044 –0.089; 0.001 0.053 
Protein E%       
TC genotype  –0.152 –0.616; 0.311 0.520 0.568 –1.196; 2.333 0.528 
CC genotype  –0.286 –0.863; 0.291 0.332 –0.793 –2.954; 1.367 0.472 
TC genotype × time    –0.015 –0.109; 0.078 0.746 
CC genotype × time    0.076 –0.038; 0.190 0.189 
Lipids E%       
TC genotype  –1.018 –1.990; –0.046 0.040 –0.178 –4.137; 3.782 0.930 
CC genotype  –0.102 –1.309; 1.105 0.869 3.044 –1.815; 7.904 0.219 
TC genotype × time    0.008 –0.189; 0.204 0.939 
CC genotype × time    –0.154 –0.394; 0.087 0.210 
Carbohydrates E%       
TC genotype  0.839 –0.342; 2.020 0.164 –0.079 –4.460; 4.302 0.972 
CC genotype  0.424 –1.043; 1.892 0.571 –1.506 –6.877; 3.865 0.583 
TC genotype × time    –0.014 –0.239; 0.212 0.906 
CC genotype × time    0.043 –0.233; 0.318 0.762 
1Coefficient can be interpreted as the mean difference in daily energy intake (kcal), nutrient intake (g/kg) and nutrient 
intake as a percentage from daily energy intake (E%) between FTO rs1421085 TC and TT genotype or between CC and TT 
genotype at each timepoint. 
2Difference in the rate of change in daily energy intake (kcal), nutrient intake (g/kg) and nutrient intake as a percentage 
from daily energy intake (E%) between FTO rs1421085 TC and TT genotype or between CC and TT genotype can be 
calculated as the sum of main effect coefficient and time × interaction coefficient at given timepoint. 
3 Average sample size by sex and FTO rs1421085 genotype at age 15, 18, and 25 years: male subjects TT = 153/119/128, CT = 231/200/204, 
CC= 97/81/86; female subjects TT = 182/154/155, CT = 288/256/244, CC = 123/103/109, respectively.  
 
 
 
 
 
 
 
 
 
29 
 
Table 5. The rate of change per year in daily energy intake (kcal), nutrient intake (g/kg) and nutrient 
intake as a percentage from daily energy intake (E%) (mean and 95% CI) in the female subjects of the 
ECPBHS sample according to the linear mixed effects regression model with FTO rs1421085 genotype 
× time interaction. 
 TT genotype TC genotype CC genotype 
Energy intake (kcal/kg) –11.362 (–23.903; 1.179)* –23.803 (–33.746; –13.861) –31.788 (–46.774; –16.802)* 
Protein (g/kg) 0.004 (–0.004; 0.012)# –0.006 (–0.012; 0.001)# –0.004 (–0.013; 0.006) 
Lipids (g/kg) –0.017 (–0.029; –0.005)* –0.024 (–0.034; –0.015) –0.037 (–0.051; –0.022)* 
Carbohydrates (g/kg) –0.089 (–0.118; 0.061) –0.120 (–0.142; –0.097)# –0.133 (–0.168; –0.099)# 
Protein E% 0.274 (0.201; 347) 0.259 (0.201; 0.316) 0.350 (0.263; 0.437) 
Lipids E% 0.088 (–0.066; 0.243) 0.096 (–0.026; 0.218) –0.065 (–0.250; 0.119) 
Carbohydrates E% –0.048 (–0.657; –0.304) –0.494 (–0.634; –0.354) –0.438 (–0.649; –0.226) 
* p < 0.05 significant difference in the rate of change between FTO rs1421085 genotype TT and CC  
# 0.05 ≤ p < 0.10 trend in the rate of change between FTO rs1421085 genotype TT and TC or TT and CC  
 
 
 
Table 6. Estimated main effects (mean and 95% CI) of the ECPBHS sample in maximum power output 
per kilogram body mass (MPO per kg) and standardized physical activity score from 15 to 25 years of 
age between FTO rs1421085 genotype according to the non-linear mixed effects regression model. 
 MALE2 FEMALE2 
 Coefficient1 95% CI p value Coefficient1 95% CI p value 
MPO per kg       
TC genotype  –0.095 –0.201; 0.011 0.080 0.058 –0.010; 0.126 0.092 
CC genotype  –0.088 -0.220; 0.044 0.192 –0.001 –0.085; 0.082 0.975 
Standardized physical 
activity score 
      
TC genotype  –0.040 –0.178; 0.097 0.563 0.103 –0.025; 0.232 0.116 
CC genotype  0.099 –0.072; 0.270 0.255 0.162 0.003; 0.321 0.046 
1Coefficient can be interpreted as the mean difference in MPO per kilogram body mass and standardized physical activity score between 
FTO rs1421085 TC and TT genotype or between CC and TT genotype at every fixed timepoint. 
2 Average sample size by sex and FTO rs1421085 genotype at age 15, 18, and 25 years: male subjects TT = 153/119/128, CT = 231/200/204, 
CC= 97/81/86; female subjects TT = 182/154/155, CT = 288/256/244, CC = 123/103/109, respectively.  
 
Table 7. Estimated main effects (mean and 95% CI) in male and female subjects of the ECPBHS 
sample in standardized socioeconomic status (SES) score from 15 to 25 years of age between FTO 
rs1421085 genotype according to the linear mixed effects regression model. 
 MALE2 FEMALE2 
 Coefficient1 95% CI p value Coefficient1 95% CI p value 
Standardized SES score      
TC genotype  0.198 0.038; 0.358 0.015 –0.032 –0.196 0.132 
CC genotype  0.240 0.038; 0.441 0.020 0.075 –0.127 0.277 
1Coefficient (Coeff.) can be interpreted as the mean difference in standardized socioeconomic status score between FTO rs1421085 TC and 
TT genotype or between CC and TT genotype at each timepoint. 
2 Average sample size by sex and FTO rs1421085 genotype at age 15, 18, and 25 years: male subjects TT = 153/119/128, CT = 231/200/204, 
CC= 97/81/86; female subjects TT = 182/154/155, CT = 288/256/244, CC = 123/103/109, respectively.  
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FIGURE LEGENDS 
Figure 1. Association between FTO rs1421085 genotype and body mass index (BMI), daily 
energy intake (kcal/day), standardized physical activity (sPA) score and standardized 
socioeconomic status (sSES) score from 15 to 25 years of age in male (graph A) and female 
(graph B) subjects. 
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